Vimarsana
Biggest News Aggregation in the World

Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmaceuticals . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmaceuticals Today - Breaking & Trending Today

AstraZeneca Plc Digital Transformation Strateg Report 2023: Technology Focus, Initiatives, Acquisitions, Partnership and Acquisition Network Map, ICT Budget, and Contracts - Vimarsana News

AstraZeneca Plc Digital Transformation Strateg Report 2023: Technology Focus, Initiatives, Acquisitions, Partnership and Acquisition Network Map, ICT Budget, and Contracts

/PRNewswire/ -- The "AstraZeneca Plc - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering. This report...

CEO of Kelun-Biotech Dr. Micheal Ge delivered a presentation on The 42nd JPM Annual Healthcare Conference - Vimarsana News

CEO of Kelun-Biotech Dr. Micheal Ge delivered a presentation on The 42nd JPM Annual Healthcare Conference

/PRNewswire/ -- The 42nd J.P. Morgan Annual Healthcare Conference("JPMHC")2024 is taking place on January 8-11 at San Fracisco, USA, members of Sichuan...

WBA (Walgreens Boots Alliance) Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, Partnership, Investment & Acquisition Network Map, and Other Innovation Programs - Vimarsana News

WBA (Walgreens Boots Alliance) Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, Partnership, Investment & Acquisition Network Map, and Other Innovation Programs

/PRNewswire/ -- The "WBA - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering. Walgreens Boots Alliance Inc...

Samsung Biologics presents 2024 business plans at J.P. Morgan Healthcare Conference - Vimarsana News

Samsung Biologics presents 2024 business plans at J.P. Morgan Healthcare Conference

/PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today presented its 2024 business...

Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib (ABSK021) - Vimarsana News

Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib (ABSK021)

/PRNewswire/ -- On January 9, 2024 (Beijing Time), Abbisko Therapeutics (HKEX code: 02256) announced that its investigational innovative CSF-1R inhibitor...